Ravuconazole structure
|
Common Name | Ravuconazole | ||
|---|---|---|---|---|
| CAS Number | 170864-29-6 | Molecular Weight | 437.46500 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H17F2N5OS | Melting Point | 148-151°C | |
| MSDS | N/A | Flash Point | N/A | |
| Name | Ravuconazole |
|---|---|
| Synonym | More Synonyms |
| Melting Point | 148-151°C |
|---|---|
| Molecular Formula | C22H17F2N5OS |
| Molecular Weight | 437.46500 |
| Exact Mass | 437.11200 |
| PSA | 115.86000 |
| LogP | 4.24298 |
| Storage condition | -20?C Freezer |
|
~%
Ravuconazole CAS#:170864-29-6 |
| Literature: Eisai Co., Ltd. Patent: EP1231210 A2, 2002 ; Location in patent: Page 75 ; |
| (2R,3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-buta n-2-ol |
| 3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
| N-Boc-dolaproline |
| (1R,2R)-4-[2-[2-(2,4-difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl]-benzonitrile |
| (2R,3R)-3-[(2S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl]-3-methoxy-2-methylpropanoic acid |
| N-(tert-Butoxycarbonyl)-(2R,3R,2'S)-dolaproine |
| (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid |
| (2R,3R,2'S)-3-(N-tert-butoxycarbonyl-2'-pyrrolidinyl)-3-methoxy-2-methylpropanoic acid |
| (2R,3R,4S)-3-(N-tert-butoxycarbonyl-2'-pyrrolidinyl)-3-methoxy-2-methyl-propanoic acid |